April 16, 2021 6:10 AM By Brandon Lee
Lawmakers seeking to lower drug costs should take a comprehensive approach rather than focus solely on manufacturersâ pricing practicesâa strategy thatâs only created disparities in the marketplace, policy analysts say.
Drug pricing will come back to the forefront of policy discussions in the coming months as Covid-19 vaccines become more readily available and lawmakers turn to other issues. But many of the roughly two dozen bills floating around Congress primarily address the prices drug companies set and ignore other aspects of the supply chain, including the pharmacy middlemen that control how insurance pays for medications.
Companies with lobbyists raked in Covid contracts politico.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from politico.com Daily Mail and Mail on Sunday newspapers.